The Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV ( SATURN-HIV ) trial is a randomized , double-blind , placebo-controlled study , designed to investigate the effects of rosuvastatin ( 10 mg/daily ) on markers of cardiovascular disease risk in ART-treated human immunodeficiency virus ( HIV ) - infected subjects .